SW
DAWN

SteelPeak Wealth’s Day One Biopharmaceuticals DAWN Stock Holding History

SteelPeak Wealth’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Hold
0
– -$35.8K – 605
2025
Q2 		– Hold
0
– – – 553
2025
Q1 		– Hold
0
– – – 554
2024
Q4 		– Hold
0
– – – 540

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

SteelPeak Wealth's DAWN Position: Q3 2025 in Review

SteelPeak Wealth sold out of Day One Biopharmaceuticals (DAWN) in Q3 2025, closing a stake of 10,000 shares — an estimated $65K sold.

SteelPeak Wealth first reported a position in DAWN in Q2 2024 and held it in 5 quarters. The position peaked at $242K in Q3 2024. 172 funds tracked by Wall St. Rank hold DAWN as of Q3 2025.

  • SteelPeak Wealth reported no remaining Day One Biopharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • SteelPeak Wealth sold 10,000 Day One Biopharmaceuticals shares in Q3 2025, an estimated $65K.
  • SteelPeak Wealth first reported a position in Day One Biopharmaceuticals in Q2 2024 and held it in 5 quarters.
  • SteelPeak Wealth's Day One Biopharmaceuticals position peaked at $242K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2025.

Based on SteelPeak Wealth's 13F filing for Q3 2025, filed 21 Oct 2025.